Head to Head Survey: Nutex Health (NASDAQ:NUTX) & Medpace (NASDAQ:MEDP)

Medpace (NASDAQ:MEDP) and Nutex Health (NASDAQ:NUTX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Profitability

This table compares Medpace and Nutex Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medpace	18.36%	91.88%	23.65%
Nutex Health	11.62%	37.44%	14.16%

Earnings and Valuation

This table compares Medpace and Nutex Health”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.11 billion	7.24	$404.39 million	$14.30	37.90
Nutex Health	$479.95 million	1.47	$52.10 million	$18.49	5.40

Medpace has higher revenue and earnings than Nutex Health. Nutex Health is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Medpace and Nutex Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	3	9	2	0	1.93
Nutex Health	0	1	2	0	2.67

Medpace currently has a consensus price target of $491.27, indicating a potential downside of 9.37%. Nutex Health has a consensus price target of $252.50, indicating a potential upside of 152.75%. Given Nutex Health’s stronger consensus rating and higher possible upside, analysts clearly believe Nutex Health is more favorable than Medpace.

Insider and Institutional Ownership

78.0% of Medpace shares are held by institutional investors. Comparatively, 5.3% of Nutex Health shares are held by institutional investors. 20.3% of Medpace shares are held by company insiders. Comparatively, 36.9% of Nutex Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Volatility & Risk

Medpace has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500. Comparatively, Nutex Health has a beta of -0.01, meaning that its share price is 101% less volatile than the S&P 500.

Summary

Medpace beats Nutex Health on 9 of the 13 factors compared between the two stocks.

About Medpace

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

About Nutex Health

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.